How to Apply to Lonza

16 min read Last updated April 20, 2026 227 open positions
Blake Crosley
Blake Crosley Researched using publicly available information, hiring data, and ATS analysis.

Key Takeaways

  • Lonza is the world's largest pure-play biopharma CDMO, headquartered in Basel and operating roughly 30+ manufacturing sites globally. It manufactures other companies' drugs and is best known publicly for being Moderna's lead COVID-19 vaccine partner at Visp.
  • The company is in the middle of a major strategic reset: CEO Pierre-Alain Ruffieux departed in late 2023 under shareholder pressure, Wolfgang Wienand (ex-Siegfried CEO) took over in June 2024, the CHI division was sold to Bain Capital for ~CHF 2.6B, and the Vacaville California site was acquired from Roche/Genentech for ~$1.2B.
  • The applicant tracking system is Workday Recruiting (lonza.wd3.myworkdayjobs.com via careers.lonza.com). There is no separate ATS for any business unit. Workday parses single-column PDFs cleanly and breaks on visually creative layouts.
  • Site selection matters. Visp is biologics, mRNA, and small molecules at scale; Vacaville is large-scale mAbs; Slough, Houston, and Geleen are cell and gene therapy; Singapore Tuas and Hayward are biologics. Apply to the site that matches your background.
  • The U.S. BIOSECURE Act is a real tailwind for Lonza versus Chinese CDMOs (notably WuXi Biologics) and is driving Western pharma sponsors to diversify capacity. This is fueling demand and hiring at Western sites.
  • Interviews are technical, structured, and Swiss-direct. Bluffing fails fast; specific, evidence-based answers about your hands-on experience are rewarded. For scientists, expect a 30-45 minute presentation of prior work followed by panel Q&A.
  • Languages matter at site level. English is universal; German is a strong asset at any Swiss site; French is genuinely useful at Visp; Italian helps at Verbania. Be honest about CEFR levels because interviewers verify them mid-conversation.
  • There are no guarantees. The post-2024 reset, COVID windfall wind-down, Capsules divestiture, Vacaville integration, and CHF cost pressure are all real organizational realities. Candidates who can operate through ambiguity and change will do better than those who need a fully settled environment.

About Lonza

Lonza Group AG (SIX: LONN) is a Swiss life-sciences company headquartered in Basel and is the world's largest pure-play biopharma contract development and manufacturing organization, known throughout the industry simply as a CDMO. Founded in 1897 as an electrochemical works in the Valais village of Gampel and later anchored at its sprawling Visp campus, Lonza spent its first century as a chemicals and intermediates business before pivoting decisively in the 1990s and 2000s into pharmaceutical and biotech manufacturing. Today the company employs roughly 16,000 to 18,000 people across more than 30 manufacturing facilities on four continents and serves essentially every major pharmaceutical and biotech client, including Pfizer, Moderna, Bristol-Myers Squibb, Novartis, Roche, GSK, Sanofi, AstraZeneca, and a long tail of smaller biotechs. Lonza does not sell drugs under its own brand. Instead, it manufactures other companies' molecules under contract, spanning monoclonal antibodies, recombinant proteins, small-molecule active pharmaceutical ingredients, mRNA, viral vectors, and cell and gene therapies. The Visp site in the Swiss Valais is the company's largest production complex and is best known publicly as the lead manufacturing partner for Moderna's COVID-19 vaccine mRNA-1273, a contract that drove an unprecedented capacity build during 2020 and 2021. As the COVID-19 vaccine demand has wound down through 2024 and 2025, Lonza has been actively repurposing that mRNA capacity for other clients and modalities. The company is currently in the middle of the most significant strategic reset of its modern history. In late 2023, then-CEO Pierre-Alain Ruffieux departed under shareholder pressure following a series of profitability disappointments, with Chair Albert Baehny stepping in as interim executive chairman. Activist investors, including Cevian Capital, pushed for a sharper portfolio focus. In May 2024 the company announced the sale of its Capsules and Health Ingredients (CHI) division to Bain Capital for approximately CHF 2.6 billion, a transaction that closed in 2025 and turned Lonza into a pure-play biopharma CDMO. In the same period Lonza acquired the large-scale monoclonal antibody manufacturing site in Vacaville, California from Roche/Genentech for roughly $1.2 billion, adding a marquee biologics asset on the U.S. West Coast. Wolfgang Wienand, formerly CEO of Swiss CDMO competitor Siegfried Holding, took over as Lonza CEO in June 2024 and is now leading what the company describes as a return to focused, profitable growth. The competitive landscape is intense. On biologics, Lonza competes head-to-head with Samsung Biologics (which has overtaken Lonza in raw biologics capacity), WuXi Biologics, Catalent (now owned by Novo Holdings), Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, and AGC Biologics. On small molecules it competes with Patheon (Thermo Fisher), Cambrex, Recipharm, and its old peer Siegfried. On cell and gene therapy it competes with Catalent, Oxford Biomedica, and Charles River Laboratories. The U.S. BIOSECURE Act, advancing through Congress in 2024 and 2025, is an unambiguous tailwind for Lonza because it restricts U.S. federal contracting with certain Chinese CDMOs, most notably WuXi Biologics, and Western pharma sponsors are actively diversifying away from Chinese capacity. Lonza is a Swiss employer at its core, governed by Swiss federal labor law at the Basel headquarters, the Visp and Stein campuses, and at its Czech facility in Kouřim, with local labor frameworks at sites in the United States (Vacaville, Hayward, Houston, and others), the United Kingdom (Slough), the Netherlands (Geleen), Singapore (Tuas), Italy (Verbania), Spain (Madrid), and beyond. English is the global working language; German is useful at most Swiss sites; French is genuinely useful in Visp, which sits in the bilingual Valais canton; and Italian helps in Verbania. The work is technical, regulated, and precise. If you want stable, science-led, GMP-disciplined careers at a company that quietly underpins a meaningful share of the world's medicines, Lonza is one of the most consequential employers in the industry. If you want a fast-moving consumer-tech culture or guaranteed annual reorganizations of strategy, this is not it — though the 2024-2025 reset means there is genuine organizational uncertainty in some functions during the Wienand turnaround era.

Application Process

  1. 1
    Start at the official Lonza careers portal

    Start at the official Lonza careers portal. Roles are posted at careers.lonza.com, which is backed by Workday Recruiting. Most postings link through to the Workday tenant at lonza.wd3.myworkdayjobs.com. Avoid third-party aggregators when possible — they often surface stale or expired requisitions, and many Lonza postings are managed by site-specific recruiters who only review applications submitted through the official portal.

  2. 2
    Filter by site, function, and modality

    Filter by site, function, and modality. Lonza's site network is large and the work is genuinely different from one campus to another. Visp Switzerland is biologics, mRNA, and small molecules at scale; Slough UK is cell and gene therapy; Vacaville California is large-scale monoclonal antibodies (the new Roche/Genentech asset); Houston Texas is cell and gene; Geleen Netherlands is cell and gene; Singapore Tuas is biologics; Hayward California is biologics. Decide which site and modality match your background before applying, because internal recruiters group requisitions by site team.

  3. 3
    Create a Workday profile and reuse it across requisitions

    Create a Workday profile and reuse it across requisitions. Workday profiles are tenant-specific, so your Lonza profile does not carry to Novartis, Roche, or any other employer. Within the Lonza tenant, however, a single profile lets you apply to multiple roles without re-entering work history. Upload a clean ATS-readable PDF or .docx, let Workday parse it, then manually correct the parsed fields, especially for European date formats, accented characters, and degree titles (Dipl.-Ing., M.Sc., Ph.D., Dr. rer. nat.).

  4. 4
    For early-career and graduate roles, look for the dedicated programs

    For early-career and graduate roles, look for the dedicated programs. Lonza runs a Global Graduate Program, an apprenticeship (Lehre) system at Visp and Stein for Swiss vocational pathways including chemistry and laboratory technician (Chemikant, Laborant), and structured intern and PhD programs. The apprenticeship and Lehre tracks are governed by the Swiss federal vocational system (Berufsbildung) and have specific application windows tied to the August school-year start.

  5. 5
    For experienced manufacturing and operator roles, expect a site-specific funnel

    For experienced manufacturing and operator roles, expect a site-specific funnel. Process operators, manufacturing technicians, GMP technicians, and shift-based production roles are typically interviewed by the site team directly, often with a plant tour, a shift-pattern conversation, and a practical or scenario-based discussion. These hires move faster than R&D roles, sometimes from application to start in 4 to 8 weeks.

  6. 6
    For scientific and process development roles, expect a long, technical funnel

    For scientific and process development roles, expect a long, technical funnel. Bioprocess engineers, upstream and downstream scientists, analytical scientists, formulation scientists, and PhD-level R&D roles will go through 4 to 6 rounds: recruiter screen, hiring manager screen, technical interviews with multiple team members (often including a presentation of your prior work), a site visit if not already done, and a final discussion with the head of the function or site.

  7. 7
    For commercial and business development roles, expect client-facing scrutiny

    For commercial and business development roles, expect client-facing scrutiny. Lonza's customers are large pharma sponsors paying eight- and nine-figure contracts. BD, account management, project management, and program management interviews will probe your direct experience with biopharma clients, your understanding of CDMO economics (capacity reservation fees, milestone payments, scale-up risk allocation), and your ability to speak credibly about specific modalities such as mAbs, ADCs, viral vectors, or cell therapies.

  8. 8
    Complete background checks, references, and (in regulated roles) GMP-related dis

    Complete background checks, references, and (in regulated roles) GMP-related disclosures. Lonza performs employment verification, education verification, criminal background checks, and for some sites credit checks, with timelines that vary by jurisdiction. Swiss roles often require a current criminal record extract (Strafregisterauszug). U.S. roles may include drug screening for safety-sensitive manufacturing positions. Allow 4 to 8 weeks from offer to start date for international hires, longer if a work permit is required.

  9. 9
    Negotiate the full package, not just base

    Negotiate the full package, not just base. Lonza compensation typically includes base salary, an annual short-term incentive tied to company and individual performance, long-term incentive equity for senior roles, pension contributions (a meaningful element in Switzerland and the Netherlands), relocation support for international placements, and at certain Swiss sites a 13th-month salary structured into the annual package. Be explicit about which currency the offer is denominated in; CHF strength has been a recurring theme in negotiations.

Resume Tips for Lonza

recommended

Lead with the modality and the scale

Lead with the modality and the scale. A bullet that reads 'Process development scientist' is invisible. 'Led upstream process development for a 2,000 L single-use mAb campaign, achieving 3.2 g/L titer at GMP transfer' gets read. Lonza recruiters and hiring managers screen first for modality fluency (mAb, ADC, mRNA, AAV, lentivirus, autologous cell therapy) and second for scale (bench, pilot, clinical, commercial).

recommended

Use the right technical vocabulary for upstream and downstream work

Use the right technical vocabulary for upstream and downstream work. Upstream: cell line development, CHO, HEK293, perfusion vs fed-batch, bioreactor scale (2 L, 50 L, 200 L, 500 L, 2,000 L), titer, viability, productivity. Downstream: Protein A capture, ion exchange, HIC, viral inactivation, viral filtration, UF/DF, formulation. Analytical: SEC-HPLC, CE-SDS, icIEF, peptide mapping, host cell protein assays. Mirror the exact terms used in the job posting.

recommended

For GMP manufacturing roles, lead with regulatory exposure

For GMP manufacturing roles, lead with regulatory exposure. List the regulatory agencies whose inspections you have been part of (FDA, EMA, Swissmedic, MHRA, PMDA, ANVISA), the standards you have worked under (21 CFR Parts 210/211/600, ICH Q7/Q9/Q10, EU Annex 1 for sterile manufacturing, EudraLex Volume 4), and the deviation, CAPA, and change-control systems you have run. Inspection-readiness is a real currency.

recommended

For cell and gene therapy roles, separate autologous from allogeneic experience

For cell and gene therapy roles, separate autologous from allogeneic experience. The two manufacturing models are very different — autologous is single-patient, single-batch, with chain-of-identity and chain-of-custody requirements; allogeneic is bank-derived and looks more like classical biologics. Be explicit about which one your experience covers. Viral vector experience (AAV serotype, lentivirus, transient transfection vs stable line) belongs at the top.

recommended

For small molecule API roles, include the chemistry and the scale

For small molecule API roles, include the chemistry and the scale. Reaction types, route selection, hazard assessment (DSC, ARC, RC1), kilo-lab and pilot-plant experience, Class 1/2/3 solvent handling, ICH Q3 impurity profiling, and OEB (occupational exposure band) experience for highly potent APIs all matter. Lonza runs HPAPI capability and screens for it explicitly.

recommended

For PhD and process development scientists, include a brief publications block a

For PhD and process development scientists, include a brief publications block and patent list. CDMO clients sometimes review the resumes of senior scientists assigned to their programs; demonstrated peer-reviewed work and patent inventorship is a credibility signal. Keep it to 4 to 6 most-relevant items, not the full bibliography.

recommended

List languages with CEFR levels (A2/B1/B2/C1/C2)

List languages with CEFR levels (A2/B1/B2/C1/C2). English is mandatory globally. German at B2 or higher is a strong asset for any Swiss site. French at B1 or higher is genuinely useful at Visp. Italian helps at Verbania. Mandarin is useful for client-facing roles supporting Asian biotech sponsors. Be honest — Lonza interviewers will switch languages mid-conversation to verify.

recommended

For commercial, BD, and program management roles, quantify program scale

For commercial, BD, and program management roles, quantify program scale. 'Managed CDMO program with $XXM total contract value across early phase to commercial,' 'Closed three Phase 3 manufacturing slots representing $XX in capacity reservation,' 'Owned client P&L of $XXM annual.' Pharma BD is a relationship business but the resume bar is still numbers.

recommended

Keep formatting boring

Keep formatting boring. Single column, standard font (Arial, Calibri, Helvetica, Times New Roman, 10-12 pt body), no tables, no graphics, no headers or footers, no two-column layouts, no photos. Workday's parser handles plain layouts cleanly and breaks on anything visually clever. Save as PDF unless the posting specifically requests .docx.

recommended

Use the exact job description keywords

Use the exact job description keywords. Workday scores resume-to-JD keyword match and Lonza recruiters filter on it. If the posting says 'single-use bioreactors,' do not write 'disposable fermenters.' If it says 'tech transfer to commercial,' do not write 'manufacturing scale-up.' Mirror the employer's language and then back it up with evidence.

ATS System: Workday Recruiting

Lonza runs Workday Recruiting as its global applicant tracking system. The candidate-facing portal is hosted at careers.lonza.com and routes through the Workday tenant at lonza.wd3.myworkdayjobs.com. The experience is the standard Workday candidate flow: create an account, upload your resume for automated parsing, confirm or correct the parsed fields, complete employment and education history, answer screening questions tailored to the requisition (which can include EEO disclosures in the United States, GMP and regulatory experience checkboxes, work-permit questions, and language proficiency selectors), and track your status through the candidate dashboard. The Workday parser performs well on single-column, plain-text PDFs and Word documents but commonly mishandles European date formats (DD.MM.YYYY versus MM/DD/YYYY), accented characters in names and place names, German-style degree titles (Dipl.-Ing., Dr. rer. nat., M.Sc.), and two-column or graphic-heavy layouts. Always review and manually correct every parsed field before submitting; recruiters filter on the structured Workday fields, not the raw resume text. Lonza's site-specific recruiters often add a short set of custom screening questions (typical examples: 'Do you have current authorization to work in Switzerland without sponsorship?', 'Have you participated in an FDA or EMA regulatory inspection in the past three years?', 'Which bioreactor scales have you worked at?'). Treat these questions as scored — short, specific, accurate answers outperform long paragraphs. Lonza does not appear to operate a separate Greenhouse or Lever instance for any business unit; the Workday tenant is the canonical front door for all functions including manufacturing, R&D, commercial, and corporate.

  • Use a single-column, standard-font (Arial, Calibri, Helvetica, Times New Roman) PDF or .docx. Avoid tables, text boxes, headers/footers, photos, and graphics — they break Workday's parser.
  • Upload the resume first, let Workday auto-fill the structured fields, then correct every error. Skipping the correction step is the most common cause of silent disqualification.
  • Mirror the job description's exact phrasing for required skills, modalities, and tools. Workday scores keyword match and Lonza recruiters filter on it.
  • Fully populate the Experience, Education, Skills, Languages, and Certifications sections — not just the resume upload. Recruiters filter using the structured fields, not raw resume text.
  • Answer every screening question, including optional EEO disclosures where applicable. Unanswered optional questions are sometimes used as a tiebreaker.
  • Be precise on work authorization. Lonza does not sponsor work permits in every jurisdiction, especially for non-PhD roles in Switzerland; misanswering this question wastes both sides' time.
  • Apply to two or three roles that genuinely fit your background, not ten. Workday flags candidates who mass-apply across a single tenant and recruiters share notes internally.

Interview Culture

Interviews at Lonza are technical, structured, and Swiss-direct.

The company is a regulated GMP manufacturer, which means interviewers are screening first for technical correctness and second for cultural fit; soft-skills theater that works at a consumer brand or a software shop tends to fall flat. Expect interviewers to ask precise, sometimes pointed, questions about your hands-on experience and to push back on vague answers. The correct response is calm, evidence-based, and specific: cite the molecule (or anonymized program), the scale, the result, the deviation if there was one, and what you learned. Saying 'I don't know' is acceptable and respected; bluffing is not. For scientific and process development roles, the most important round is typically a technical presentation. Candidates are asked to present 30 to 45 minutes of prior work — your PhD thesis, a representative project from a current employer (within confidentiality bounds), or a published paper — followed by 30 to 45 minutes of Q&A from a panel of senior scientists. Expect questions about your assumptions, your statistics, your scale-up risks, and your willingness to defend choices you made. Bring slides; have a backup PDF on a USB stick; assume the projector will not cooperate. For manufacturing operator and technician roles, expect a plant tour and a practical conversation. Interviewers will walk you through the relevant production area in gowning and ask you to describe how you would handle specific scenarios: a deviation during a critical step, a colleague who skipped a step, a temperature excursion outside acceptance criteria. The screening is for GMP discipline, attention to detail, and willingness to escalate problems rather than hide them. For commercial, BD, and program management roles, expect client-simulation rounds. You may be given a redacted scope-of-work document and asked to talk through how you would price it, what risks you see, and how you would structure the contract milestones. For senior BD hires, expect to defend a specific account strategy in front of senior commercial leadership. The leadership change matters culturally. Wolfgang Wienand, who took over as CEO in June 2024 from interim chairman Albert Baehny following Pierre-Alain Ruffieux's departure in November 2023, is widely respected in the industry from his time as CEO of Siegfried Holding. The Wienand turnaround era is meaningfully different in tone from the 2021-2023 period — more focus on operational discipline, customer outcomes, and execution; less emphasis on aspirational growth narratives. Interviewers in 2025 and 2026 are explicitly screening for candidates who are comfortable with the strategic reset, the CHI divestiture, the Vacaville integration, and the real possibility that some structures will continue to change as the new strategy lands. Dress code is business or smart business for HQ and senior interviews in Basel; smart casual is acceptable for site interviews and for technician roles. Punctuality is non-negotiable in Switzerland; arrive 10 minutes early, not earlier and not later. Have specific, well-researched questions ready about the site, the program, the modality, and the team. Asking generic questions about company culture or vague questions about growth will read as unprepared. Asking sharp questions about technology platforms, capacity utilization, client mix (without expecting names), or how the team handled a recent regulatory inspection will read as serious.

What Lonza Looks For

  • Technical depth in a specific modality — mAbs, ADCs, mRNA, viral vectors, cell therapy, or small molecule API. Lonza is a science-led company and depth beats breadth, especially for R&D and process development hires.
  • GMP discipline and regulatory fluency. Comfort working under 21 CFR Parts 210/211, EU GMP Annex 1, ICH guidelines, and direct experience supporting FDA, EMA, Swissmedic, MHRA, or PMDA inspections is a strong differentiator.
  • Tech-transfer and scale-up track record. CDMOs live and die on moving processes from clients (or from clinical to commercial) without losing yield, quality, or schedule. Demonstrated tech-transfer experience at meaningful scale is a top signal.
  • Customer mindset for client-facing roles. CDMO project managers, BD, and senior scientists are explicitly the face of Lonza to large pharma sponsors; calm, precise, and credible client communication is interviewed for directly.
  • Cost and yield discipline. Process improvements that lifted titer, reduced cycle time, lowered cost per gram, or improved right-first-time release rates are the metrics that recur in interview discussions.
  • Multilingual capability for site-specific roles. Business English is mandatory globally. German is a strong plus for Swiss sites, French is meaningfully useful at Visp, Italian helps at Verbania, and Dutch helps at Geleen.
  • Comfort with the post-2024 strategic reset. The CHI divestiture, Vacaville integration, and Wienand-era reorganization mean candidates who need a fully settled organization will struggle; candidates who can operate calmly through change are valued.
  • Long-term, mission-aligned commitment. The biopharma CDMO industry rewards engineers and scientists who stay with a process for 3 to 7 years through development, qualification, validation, and commercial launch. Job-hopping every 18 months is harder to defend at Lonza than at a Bay Area startup.
  • Quality-first instincts. The company's tagline is built around 'science engineered to deliver' and the culture explicitly punishes shortcuts. Candidates who frame past decisions in terms of patient impact and product quality outperform candidates who frame them only in terms of speed.

Frequently Asked Questions

What is the best ATS strategy for applying to Lonza?
Apply through careers.lonza.com, which routes to Workday at lonza.wd3.myworkdayjobs.com. Use a single-column PDF resume with standard fonts and no graphics or tables. Let Workday auto-parse, then manually correct every field before submission, especially European dates, accented characters, and degree titles. Fully populate the structured Experience, Education, Skills, and Languages sections — recruiters filter on those, not on the raw resume text. Mirror the exact keywords from the job description, particularly modality terms (mAb, mRNA, AAV, ADC) and scale terms (single-use bioreactor, 2,000 L, GMP).
Does Lonza sponsor work permits in Switzerland?
Sometimes, but not for every role. Switzerland operates a quota-based work-permit system with priority for Swiss and EU/EFTA citizens. Lonza will sponsor non-EU candidates for senior scientific, leadership, and specialized roles where local talent is unavailable, but many manufacturing technician, operator, and mid-level commercial roles in Switzerland are filled only with candidates who already have the right to work. Answer the work-authorization screening question precisely; misanswering wastes both sides' time. EU/EFTA citizens face fewer barriers than non-EU candidates.
How is the post-2024 leadership change affecting hiring?
Wolfgang Wienand became CEO in June 2024, replacing interim executive chairman Albert Baehny who had stepped in after Pierre-Alain Ruffieux's departure in November 2023. The Wienand era is more focused on operational execution, cost discipline, and customer outcomes than the prior period. Hiring in 2025 and 2026 reflects that: there is real demand for biologics process engineers, cell and gene therapy specialists, and quality professionals to support the Vacaville integration and capacity ramp, and somewhat tighter discretionary hiring in corporate functions. Interviewers will explicitly probe how you respond to organizational change.
What does the Capsules and Health Ingredients divestiture mean for current and future employees?
The CHI division was sold to Bain Capital for approximately CHF 2.6 billion, with the transaction announced in May 2024 and closing in 2025. Employees in CHI transitioned to the new standalone company under Bain ownership rather than remaining at Lonza. For new applicants, this means Lonza is now a pure-play biopharma CDMO; if your background is in capsules manufacturing, dietary supplements, or consumer health ingredients, the new entity (now operating under its own brand) is the more relevant employer. For biopharma applicants, the divestiture sharpens Lonza's focus and concentrates capital on biologics, small molecules, and cell and gene therapy.
How does the Vacaville site acquisition affect U.S. hiring?
Lonza acquired the large-scale monoclonal antibody manufacturing site in Vacaville, California from Roche/Genentech for approximately $1.2 billion in 2024. The site adds significant biologics capacity on the U.S. West Coast and is a marquee asset. Hiring at Vacaville in 2025 and 2026 includes integration roles (quality, regulatory, IT, finance), expansion of operations, and process development support. Existing Roche/Genentech staff transferred with the site under typical asset-purchase terms; new hires are coming in alongside the integrated workforce. Expect site-specific cultural integration to remain an ongoing topic.
What is the BIOSECURE Act and how does it affect Lonza?
The U.S. BIOSECURE Act, advancing through Congress in 2024 and 2025, restricts U.S. federal contracting and federal funding flows from being used with certain named Chinese biotech companies, most notably WuXi Biologics, WuXi AppTec, BGI, MGI, and Complete Genomics. It is a clear tailwind for Western CDMOs including Lonza, Samsung Biologics (Korean), Catalent, Boehringer Ingelheim BioXcellence, and FUJIFILM Diosynth, because Western pharma sponsors are actively diversifying capacity away from Chinese providers. For Lonza, that has translated into stronger demand pipeline and active capacity build, particularly in the United States and Europe.
What is the difference between Workday and the older job sites I might find online?
The current canonical career portal is careers.lonza.com routing to lonza.wd3.myworkdayjobs.com. Older URLs and third-party aggregators may surface stale or expired requisitions. Apply only through the official portal; postings on LinkedIn that link back to careers.lonza.com are legitimate, but third-party reposts on generic job boards may be expired or out of date. If a posting on a third-party site is more than 30 days old without a verifiable listing on careers.lonza.com, treat it as expired.
Are PhDs required for scientific roles?
It depends on the role. Senior process development scientist, principal scientist, group leader, and most R&D leadership roles are effectively PhD-only or require equivalent industry experience (typically 8 to 10 years of hands-on bioprocess work in lieu of the degree). Associate scientist, scientist I, and analytical scientist roles can be filled with M.Sc. plus 2 to 5 years of industry experience. Manufacturing technician, operator, and quality control technician roles do not require a PhD; they typically require a relevant technical apprenticeship (Lehre in Switzerland), associate degree, or bachelor's degree depending on the country and the level.
What languages do I need for Swiss sites?
English is the global working language and is mandatory at all sites. For Basel, German at B2 or higher is a real asset and is often expected for site-floor manufacturing roles, though many corporate and senior scientific roles operate in English-only environments. For Visp, the Valais canton is bilingual German-French, and French at B1 or higher is genuinely useful, though German typically dominates the Visp site itself. For Stein, German is the working language. Apprenticeship and operator roles at Visp and Stein generally require German or French depending on the team. Be honest about CEFR levels in your application; interviewers will switch languages to verify.
How long does the hiring process take?
It varies by role family. Manufacturing operator and technician roles often move from application to start in 4 to 8 weeks. Scientific and process development roles typically take 8 to 16 weeks given the technical presentation round, multi-stage panel interviews, and reference checks. Senior leadership roles can take 4 to 6 months. International hires requiring work permits add 4 to 12 weeks on the back end depending on jurisdiction. Site visits for senior or relocating candidates may add 2 to 3 weeks. The Wienand-era reorganization has not, by reported candidate experience, materially slowed hiring timelines for in-demand technical roles.
What is compensation like and is it negotiable?
Lonza compensation is competitive within the Swiss biopharma market and broadly competitive globally, though not at the top of the U.S. biotech-hub range. Packages typically include base salary, an annual short-term incentive bonus tied to company and individual performance (commonly 10-30% of base depending on level), long-term incentive equity for senior roles, pension contributions (a meaningful element in Switzerland and the Netherlands), and relocation support for international hires. Swiss sites often include a 13th-month salary structured into the annual package. Negotiation is normal and expected, especially on relocation, sign-on, and equity for senior hires; recruiters do not view counter-offers as a red flag, but vague or unsupported asks fall flat.
What are the biggest risks of joining Lonza right now?
Honest risks include: continued organizational change as the Wienand turnaround lands and as the Vacaville integration progresses; the wind-down of COVID-era Moderna mRNA volumes at Visp, which is still being absorbed into other client programs; CHF strength putting cost pressure on Swiss operations; intense competition from Samsung Biologics on capacity and Catalent (under Novo Holdings) on integrated services; and the inherent volatility of CDMO economics, where one client program failure or postponement can hit a site's utilization meaningfully. None of these are deal-breakers, but candidates should ask sharp questions in interviews about site utilization, client mix, and the specific program their role would support.

Open Positions

Lonza currently has 227 open positions.

Check Your Resume Before Applying → View 227 open positions at Lonza

Related Resources

Career Guides for Lonza Roles

Related Articles

Sources

  1. Lonza Group Official Careers Portal —
  2. Lonza Workday Recruiting Tenant —
  3. Lonza Group AG Investor Relations —
  4. Lonza Announces Sale of Capsules and Health Ingredients to Bain Capital —
  5. Lonza Acquires Genentech Vacaville Manufacturing Site —
  6. Lonza Appoints Wolfgang Wienand as CEO —
  7. Reuters: Lonza CEO Ruffieux to Step Down —
  8. Reuters: Lonza Strategic Update and Bain Capsules Sale —
  9. FierceBiotech: Lonza CDMO Coverage —
  10. Endpoints News: Lonza Wienand Era Coverage —
  11. U.S. BIOSECURE Act Legislative Tracker —
  12. Moderna and Lonza Manufacturing Partnership —
  13. Swiss Federal Vocational Education and Training (Berufsbildung) —
  14. Lonza Visp Site Profile —
  15. Glassdoor Lonza Interview Reviews —